We will stay on top of this issue until disclosing diversity data becomes a widely accepted practice. Read More
Related Articles
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst—priced at more than $18,000 for a 28-day supply—only because of the generosity of patient assistance foundations. Clark, 57, a former insurance agent who lives in Bixby, Okla., had to stop working in 2015 and go on Social Security disability and Medicare after being diagnosed […]
AstraZeneca acquires rare-disease Pro Alexion at $39 billion Bargain
AstraZeneca Plc, among the drugmakers directing the struggle against Covid-19, highlighted in which its expansion will come out following the pandemic having a 39 billion agreement to get rare-disease expert Alexion Pharmaceuticals Inc.. The suggested cash-and-stock acquisition will include remedies for rare blood and gynecological ailments to the portfolio of Cambridge, U.K.-based AstraZeneca, that had […]
Even a 2,000-person Royal Caribbean cruise to nowhere did Not end Nicely
A Royal Caribbean Cruises Ltd. boat comes in Singapore about which was supposed to be a day three of a four-day railway to nowhere following a favorable COVID-19 event was identified aboard early Wednesday. Approximately 2,000 passengers aboard the Quantum of those boat were informed of this development from the boat’s captain on the public announcement […]